Inactive Instrument

Calendar Aviragen Therapeutics Inc Nasdaq

Equities

US0537611024

Chart calendar Aviragen Therapeutics Inc

3c32c845257f86b82.sK0G6a-d7_dyeHV_zE1skZOrG79nO0Ixe_6cpu4pyjU.5PVT2dmpvKVLJ0Y2hzRb4fTmSYkKWS5mH5vp4557_0TWmVewxc6LlBszIA~58b47acbc14e6790427e16a3a3e15a67

Upcoming events on Aviragen Therapeutics Inc

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)

Past events on Aviragen Therapeutics Inc

2024-04-03 03:10 pm World Vaccine Congress
2024-03-14 04:30 pm Q4 2023 Earnings Call
2024-03-14 04:01 pm Q4 2023 Earnings Release
2023-11-02 04:30 pm Q3 2023 Earnings Call
2023-11-02 04:01 pm Q3 2023 Earnings Release
2023-10-19 05:00 am World Vaccine Congress - Protection against infection from an oral tablet norovirus candidate in hum
2023-10-18 08:30 am World Vaccine Congress - Transmission blocking strategies via oral tablet vaccination and mucosal im
2023-09-28 02:25 pm Cantor Global Healthcare Conference - Fireside Chat
2023-09-06 05:00 pm Monovalent Norovirus Vaccine Phase 2 Study Results Call
2023-08-03 04:30 pm Q2 2023 Earnings Call
2023-08-03 04:01 pm Q2 2023 Earnings Release
2023-06-26 01:00 pm Annual General Meeting
2023-05-04 04:30 pm Q1 2023 Earnings Call
2023-05-04 04:01 pm Q1 2023 Earnings Release
2023-04-06 12:15 pm World Vaccine Congress
2023-04-05 04:40 pm World Vaccine Congress
2023-03-28 01:00 pm Investor Meeting - Key Opinion Leader
2023-03-15 04:30 pm Q4 2022 Earnings Call
2023-03-15 04:01 pm Q4 2022 Earnings Release
2022-11-29 04:50 pm World Vaccine & Immunotherapy Congress

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
9,86
6,50
51.72%
4,05
8,05
-49.74%
0,89
1,02
-12.39%
0,11
0,79
-86.5%
7,38
5,21
41.6%

14,7

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-15,8
-15,6
-1.19%
-30,2
-22,6
-33.5%
-72,8
-75,2
3.22%
-115
-106
-8.4%
-83,3
-88,3
5.58%

-75,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-18,2
-17,9
-1.42%
-32,0
-24,2
-32.16%
-70,4
-76,3
7.78%
-108
-106
-1.4%
-82,2
-85,6
4%

-75,1

Net income
Million USD
Released
Forecast
Spread
-18,6
-18,2
-2.45%
-32,2
-24,4
-32.05%
-70,5
-76,5
7.9%
-108
-106
-1.43%
-82,5
-85,7
3.77%

-77,5

EPS
USD
Released
Forecast
Spread
-0,86
-0,66
-30.3%
-0,36
-0,28
-30.91%
-0,58
-0,66
12.45%
-0,84
-0,84
-0.6%
-0,57
-0,59
3.93%

-0,45

Announcement Date19/03/2025/02/2124/02/2215/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,07
0,18
-59.51%
0,09
0,13
-32%
0,00
0,10
-
0,00
0,05
-
0,02
0,68
-96.74%
0,68
0,80
-15.63%
1,36
0,08
1529.67%
2,10
0,10
2001%
3,25
1,10
195%

0,80


0,05


1,42


12,5

EBIT
Million USD
Released
Forecast
Spread
-24,2
-20,6
-17.55%
-24,8
-22,3
-10.95%
-29,2
-26,3
-11.17%
-29,4
-31,3
5.86%
-31,1
-30,1
-3.35%
-25,6
-25,8
0.75%
-23,1
-25,6
9.93%
-17,8
-24,9
28.48%
-16,9
-20,6
18.06%

-21,3


-22,0


-19,6


-12,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-20,7
-20,8
0.34%
-25,1
-20,4
-23.24%
-29,4
-26,6
-10.75%
-29,3
-31,5
6.94%
-23,9
-30,3
21.23%
-25,1
-25,3
0.87%
-22,5
-25,2
10.45%
-17,4
-24,5
29.09%
-17,2
-20,2
14.81%

-21,4


-22,1


-19,6


-12,1

Net income
Million USD
Released
Forecast
Spread
-20,8
-20,8
0.38%
-25,1
-20,4
-23.31%
-29,4
-26,6
-10.8%
-29,3
-31,5
6.96%
-23,9
-30,4
21.26%
-25,1
-25,4
0.91%
-22,6
-25,2
10.38%
-17,4
-24,5
28.94%
-17,4
-20,2
14.12%

-21,6


-22,4


-20,2


-13,3

EPS
USD
Released
Forecast
Spread
-0,17
-0,16
-4.94%
-0,20
-0,16
-23.08%
-0,23
-0,21
-12.2%
-0,23
-0,24
5.15%
-0,18
-0,23
20.88%
-0,19
-0,19
2.23%
-0,16
-0,18
11.11%
-0,11
-0,18
38.89%
-0,12
-0,13
10%

-0,14


-0,14


-0,12


-0,07

Announcement Date24/02/2209/05/2208/08/2208/11/2215/03/2304/05/2303/08/2302/11/2314/03/24----
  1. Stock Market
  2. Equities
  3. VXRT Stock
  4. Stock
  5. Calendar Aviragen Therapeutics Inc